LifeHealthcare Group Ltd
(ASX:LHC) has announced positive FY16 results. Some of the highlights include:
Revenue of $114.8 million (up 15.6% over pcp), EBITDA of $19.3 million (up 11.6% over pcp), and full-year dividend of 12.5 cents (71% of NPAT).
In FY16, the company launched 14 major products which generated revenue in excess of $5.5 million.
The company also has a total of 111 surgeons in FY16 (an increase of 16 surgeons over pcp).
As for its outlook, LifeHealthcare expects FY17 revenue growth to be in mid to high single digits, representing sustained above market performance.
